Alfred S.L. Cheng
Impact in
- Cancer Research top 0.5%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Molecular Biology top 1%
- Epigenetics and DNA Methylation
- RNA modifications and cancer
- Cancer-related gene regulation
- Circular RNAs in diseases
Papers in
-
- Epigenetics and DNA Methylation 28
- RNA modifications and cancer 23
- Cancer-related gene regulation 14
- Histone Deacetylase Inhibitors Research 11
-
- MicroRNA in disease regulation 13
- Cancer-related molecular mechanisms research 11
- Co-authors
- Ka‐Fai To (63 shared papers)Jun Yu (61 shared papers)Joseph J.�Y. Sung (49 shared papers)Wei Kang (36 shared papers)Francis K.L. Chan (18 shared papers)Tingting Huang (16 shared papers)Henry Lik‐Yuen Chan (18 shared papers)Wai K. Leung (9 shared papers)
- Journals
- Cancer Research (12 papers)Oncogene (11 papers)PLoS ONE (6 papers)Cancer Letters (5 papers)The Journal of Pathology (5 papers)
- Partner nations
- Hong KongChinaUnited States
In The Last Decade
Alfred S.L. Cheng
147 papers receiving 8.3k citations
Alfred S.L. Cheng's Hit Papers
Peers
Comparison fields: 5 of 116
- Cancer Research 2.1k
- Molecular Biology 4.8k
- Hepatology 437
- Oncology 1.2k
- Cell Biology 684
Countries citing papers authored by Alfred S.L. Cheng
This map shows the geographic impact of Alfred S.L. Cheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alfred S.L. Cheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alfred S.L. Cheng more than expected).
Fields of papers citing papers by Alfred S.L. Cheng
This network shows the impact of papers produced by Alfred S.L. Cheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alfred S.L. Cheng. The network helps show where Alfred S.L. Cheng may publish in the future.
Co-authors
The 25 scholars most cited alongside Alfred S.L. Cheng, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 152 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | NF-κB–YY1–miR-29 Regulatory Circuitry in Skeletal Myogenesis and Rhabdomyosarcoma Hit paper breakdown → | 2008 | 500 |
| 2 | 2008 | 476 | |
| 3 | 2000 | 226 | |
| 4 | 2006 | 194 | |
| 5 | 2011 | 181 | |
| 6 | 2009 | 176 | |
| 7 | 2017 | 170 | |
| 8 | 2009 | 163 | |
| 9 | 2016 | 156 | |
| 10 | 2013 | 154 | |
| 11 | 2021 | 147 | |
| 12 | 2006 | 147 | |
| 13 | 2017 | 134 | |
| 14 | 2010 | 131 | |
| 15 | 2013 | 128 | |
| 16 | 2022 | 125 | |
| 17 | 2012 | 121 | |
| 18 | 2018 | 118 | |
| 19 | 2017 | 116 | |
| 20 | 2012 | 116 |
About Alfred S.L. Cheng
Alfred S.L. Cheng is a scholar working on Molecular Biology, Cancer Research, Epidemiology, Cell Biology and Oncology, having authored 152 papers that have together received 8.4k indexed citations. Recurring topics across this work include Epigenetics and DNA Methylation (28 papers), RNA modifications and cancer (23 papers), Cancer-related gene regulation (14 papers), Hippo pathway signaling and YAP/TAZ (13 papers), MicroRNA in disease regulation (13 papers), Cancer-related molecular mechanisms research (11 papers), Histone Deacetylase Inhibitors Research (11 papers) and Immune cells in cancer (11 papers). The work is most often cited by research in Cancer Research (2.1k citations), Molecular Biology (4.8k citations), Hepatology (437 citations), Oncology (1.2k citations) and Cell Biology (684 citations). Alfred S.L. Cheng has collaborated with scholars based in Hong Kong, China and United States. Frequent co-authors include Ka‐Fai To, Jun Yu, Joseph J.�Y. Sung, Wei Kang, Francis K.L. Chan, Tingting Huang, Henry Lik‐Yuen Chan, Wai K. Leung, William Ka Kei Wu and Joanna H. Tong. Their work appears in journals such as Cancer Research, Oncogene, PLoS ONE, Cancer Letters and The Journal of Pathology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.